Evidence map›Paper›PMID 26624293›Full record

ArticlePloS one2015

The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE.

Puthayalai Treerat, Priyangi Alwis, Tanya D'Cruze, Meabh Cullinane, Jamunarani Vadivelu, Rodney J Devenish, Mark Prescott, Ben Adler, John D Boyce

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Profiling ofMicrobiology spectrum · 2026
    Article
  3. Experimental Approaches to Visualize Effector Protein Translocation During Host-Pathogen Interactions.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  4. Article
  5. Type III Secretion in the Melioidosis PathogenFrontiers in cellular and infection microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Puthayalai TreeratInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
Priyangi AlwisInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
Tanya D'CruzeInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
Meabh CullinaneDepartment of Microbiology, Monash University, Clayton campus, Victoria 3800, Australia.
Jamunarani VadiveluInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
Rodney J DevenishInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
Mark PrescottInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
Ben AdlerInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
John D BoyceInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton campus, Victoria 3800, Australia.
Australian Research Council · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many Gram-negative pathogens use a type III secretion system (TTSS) for the injection of bacterial effector proteins into host cells. The injected effector proteins play direct roles in modulation of host cell pathways for bacterial benefit. Burkholderia pseudomallei, the causative agent of melioidosis, expresses three different TTSSs. One of these systems, the TTSS3, is essential for escape from host endosomes and therefore intracellular survival and replication. Here we have characterized three putative TTSS3 proteins; namely BapA, BapB and BapC. By employing a tetracysteine (TC)-FlAsH™ labelling technique to monitor the secretion of TC-tagged fusion proteins, BapA and BapC were shown to be secreted during in vitro growth in a TTSS3-dependant manner, suggesting a role as TTSS3 effectors. Furthermore, we constructed B. pseudomallei bapA, bapB and bapC mutants and used the well-characterized TTSS3 effector BopE as a marker of secretion to show that BapA, BapB and BapC are not essential for the secretion process. However, BopE transcription and secretion were significantly increased in the bapB mutant, suggesting that BapB levels modulate BopE expression. In a BALB/c mouse model of acute melioidosis, the bapA, bapB and bapC mutants showed a minor reduction of in vivo fitness. Thus, this study defines BapA and BapC as novel TTSS3 effectors, BapB as a regulator of BopE production, and all three as necessary for full B. pseudomallei in vivo fitness.

Indexed as

AnimalsBacterial ProteinsBiological TransportBurkholderia pseudomalleiFemaleMelioidosisMiceMice, Inbred BALB CMutationVirulenceVirulence FactorsBacterial ProteinsVirulence Factors

Identifiers

PMID26624293
PMCPMC4666416
OpenAlexW2271431253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.